Filing Details
- Accession Number:
- 0000899243-21-046954
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-06 16:20:46
- Reporting Period:
- 2021-12-02
- Accepted Time:
- 2021-12-06 16:20:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1656536 | Decibel Therapeutics Inc. | DBTX | Pharmaceutical Preparations (2834) | 464198709 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1842132 | Anna Trask | C/O Decibel Therapeutics, Inc. 1325 Boylston Street, Suite 500 Boston MA 02215 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-12-02 | 4,913 | $6.37 | 2,620 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-12-02 | 378 | $6.34 | 2,242 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.25 to $6.615, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth in footnotes (2) and (3) of this Form 4.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.18 to $6.47, inclusive.
Billionaire Hedge Funds
